Pleiotropic Effects of Improved Apoprotein A-I Mimetic Peptide

Yoshino Matsuo, Yasunori Suematsu, Hidetaka Morita, Emi Kawachi, Takashi Kuwano, Satoshi Imaizumi, Shin-ichiro Miura


Background: To prevent the onset and progression of atherosclerotic cardiovascular disease, we previously synthesized a mimetic peptide of apolipoprotein A-I (Fukuoka University ApoA-I Mimetic Peptide (FAMP)), which is a major component of high-density lipoprotein (HDL). We reported that FAMP enhanced HDL-induced endothelial tube formation to help counteract cardiac muscle ischemia, and had anti-inflammatory effects or an effect on cholesterol efflux capacity to prevent coronary atherosclerosis.

Methods: We have now synthesized an improved FAMP (i-FAMP) and examined whether its effects are stronger than those of conventional FAMP. First, human coronary artery endothelial cells (HCECs) were used to measure the tube-forming effects of these peptides. In addition, as an anti-inflammatory effect, we also investigated their inhibitory effects on the secretion of monocyte chemotactic protein-1 (MCP-1) from cells. As an anti-apoptotic effect to prevent cardiac muscle ischemia, the inhibitory effect on caspase-3/7 activation was also measured in H9C2 rat cardiomyocyte cells.

Results: HDL promoted HCEC tube formation and suppressed MCP-1 secretion from HCECs and caspase-3/7 activation in H9C2 cells. The tube formation under HDL with i-FAMP treatment was stronger than that under HDL with FAMP. HDL in the presence of FAMP or i-FAMP significantly suppressed MCP-1 secretion compared to HDL in the absence of FAMP or i-FAMP, whereas there were no significant changes in MCP-1 secretion between HDL with FAMP and HDL with i-FAMP treatment. HDL with i-FAMP and FAMP did not enhance the suppression of caspase-3/7 activation by HDL.

Conclusions: HDL affected HCEC tube formation and had anti-inflammatory and anti-apoptotic effects; i-FAMP may or may not enhance these actions. In some cases, these effects were stronger than those of conventional FAMP.

Cell Mol Med Res. 2023;1(2):44-50


High-density lipoprotein; Apolipoprotein A-I mimetic peptide; Tube formation; Anti-inflammation; Anti-apoptotic action

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Cellular and Molecular Medicine Research, quarterly, ISSN 2817-6359 (Online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.